(Received for publication, December 24, 1996, and in revised form, March 6, 1997)
From the Center for Basic Research in Digestive
Diseases, Departments of Internal Medicine, Biochemistry, and Molecular
Biology, Mayo Clinic and Foundation, Mayo Medical School, Rochester,
Minnesota 55905 and the § Departments of Biological
Chemistry and Medicine, The Johns Hopkins University School of
Medicine, Baltimore, Maryland 21205
Although secretin is known to stimulate ductal
bile secretion by directly interacting with cholangiocytes, the precise
cellular mechanisms accounting for this choleretic effect are unknown. We have previously shown that secretin stimulates exocytosis in cholangiocytes and that these cells transport water mainly via the
water channel aquaporin-1 (AQP1). In this study, we tested the
hypothesis that secretin promotes osmotic water movement in cholangiocytes by inducing the exocytic insertion of AQP1 into plasma
membranes. Exposure of highly purified isolated rat cholangiocytes to
secretin caused significant, dose-dependent increases in
osmotic membrane water permeability (Pf)
(e.g. increased by 60% with 107
M secretin), which was reversibly inhibited by the water
channel blocker HgCl2. Immunoblotting analysis of
cholangiocyte membrane fractions showed that secretin caused up to a
3-fold increase in the amount of AQP1 in plasma membranes and a
proportional decrease in the amount of the water channel in microsomes,
suggesting a secretin-induced redistribution of AQP1 from intracellular
to plasma membranes. Both the secretin-induced increase in
cholangiocyte Pf and AQP1 redistribution were
blocked by two perturbations that inhibit secretin-stimulated
exocytosis in cholangiocytes, i.e. treatment with
colchicine and exposure at low temperatures (20 and 4 °C). Our
results demonstrate that secretin increases AQP1-mediated
Pf in cholangiocytes. Moreover, our studies implicate the microtubule-dependent vesicular translocation
of AQP1 water channels to the plasma membrane, a mechanism that appears to be essential for secretin-induced ductal bile secretion and suggests
that AQP1 can be regulated by membrane trafficking.
Bile is formed primarily by hepatocytes and secreted at the bile canaliculus; subsequently, its volume and composition are modified in the lumen of bile ducts as a result of the transport of water and solutes by cholangiocytes (1, 2). While this ductal bile secretion results from the osmotically driven movement of water, the regulatory and mechanistic aspects are obscure. We recently reported that cholangiocytes (unlike hepatocytes) express the water-selective channel protein aquaporin-1 (AQP1)1 and proposed that ductal bile secretion results from the movement of water across this protein (3, 4). Based on studies in renal epithelial cells, it is currently thought that AQP1 is constitutively inserted into plasma membranes and is not hormone responsive (5, 6).
Secretin is known to stimulate ductal bile secretion via specific receptors on cholangiocytes (7). We and others recently proposed that secretin-induced bile secretion was associated with the microtubule-dependent exocytic insertion of cytoplasmic vesicles into the cholangiocyte plasma membrane (8-10). Interestingly, hormone-regulated exocytic movement of transporters has been demonstrated in other cell types (11). For example, in renal collecting tubule cells the water channel aquaporin-2 moves to and from the apical plasma membrane in the presence and absence of vasopressin, respectively (12). For these reasons, we hypothesized that secretin stimulates ductal bile secretion by inducing the translocation of functional AQP1 water channels into the plasma membrane of cholangiocytes.
Cholangiocytes (>95% pure) were isolated from livers of male Fischer rats by enzymatic digestion and mechanical disruption and then immunopurified using Dynabeads M-450 and collected with a magnet as described previously (13). In colchicine and low temperature studies, cholangiocytes were prepared from rats 3 weeks after bile duct ligation, a maneuver that induces selective proliferation of cholangiocytes and thus generates an increased number of cells available for experiments. These cholangiocytes retain normal phenotypic features (14) and respond to secretin in a manner similar to cholangiocytes from normal rats (15). In all experiments, cell viability was greater than 90% as assessed by trypan blue exclusion. All incubations were carried out in Krebs-Ringer-HEPES buffer, pH 7.4.
Following isolation, cells were incubated according to one of three
protocols: (a) for 15 min at 37 °C in the presence of 0-106 M secretin (Peninsula Laboratories,
Belmont, CA); (b) for 1 h at 37 °C in the presence
of 50 µM colchicine or lumicolchicine (Sigma) and then
for an additional 15 min in the presence of 0 or 10
7
M secretin; (c) for 30 min at 37, 20, or 4 °C
and then for an additional 15 min in the presence of 0 or
10
7 M secretin at these temperatures.
Following incubation as described above, cells were washed and suspended in cold, 300 mosMKrebs-Ringer-HEPES buffer, pH 7.4, without CaCl2. We have previously reported that osmotic water transport in cholangiocytes is not significantly affected at low temperature (3). Therefore, in this work water transport studies were performed at 4 °C to prevent exo- and endocytic events in cholangiocytes (10) that could potentially modify a secretin-induced subcellular relocation of AQP1. The size of cholangiocytes was determined by quantitative phase contrast microscopy, a methodology previously validated (3, 4). Briefly, serial photographs of the same group of cells placed on coverslips coated with polylysine in isotonic (300 mosM) and hypotonic media (30 mosM) were digitized, and cell diameters were measured with an image analysis software program (ANALYZETM, Mayo Foundation). Cell volumes were estimated based on the spherical shape of cholangiocytes using 4.5-µm immunomagnetic beads as internal standards. The osmotic membrane water permeability (Pf) was calculated from the initial rate of cell swelling as described previously (3).
In some experiments, cholangiocytes were incubated with the known water channel blocker, HgCl2, for 5 min or with HgCl2 followed by 10 min with 2-mercaptoethanol before measuring water permeability; our previous work had shown that HgCl2 at the concentration used (0.3 mM) was not toxic for cholangiocytes (3).
Preparation of Subcellular Membrane FractionsPlasma and microsomal membrane fractions were prepared from the incubated cells by differential centrifugation. Briefly, cholangiocytes were washed and sonicated in 0.3 M sucrose containing 0.01% soybean trypsin inhibitor, 0.1 mM phenylmethanesulfonyl fluoride, and 0.1 mM leupeptin (Sigma). The immunomagnetic beads were separated using a magnet.
The plasma membrane fraction was obtained by centrifugation at 200,000 × g for 60 min on a discontinuous 1.3 M sucrose gradient as described previously (16). After removing the plasma membrane band, the sucrose gradient was sonicated, diluted to 0.3 M, and centrifuged at 17,000 × g for 30 min. The pellet obtained was designated "remaining intracellular membrane fraction," and the resulting supernatant was centrifuged at 200,000 × g for 60 min to yield the microsomal membrane fraction.
Protein concentration was determined by the fluorescamine method using bovine serum albumin as standard (17). Alkaline phosphatase activity (a plasma membrane marker) was assessed using a commercially available enzyme kit (Sigma). Microsomal esterase activity (a marker for the endoplasmic reticulum) was measured by the method of Beaufay and Berthet (18).
Immunoblotting for AQP1Solubilized cholangiocyte membrane fractions were subjected to SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose sheets. After blocking, blots were incubated overnight at 4 °C with AQP1 antiserum (19) diluted 1:500. The blots were then washed and incubated with horseradish peroxidase-conjugated goat antirabbit immunoglobulin (Tago, Inc., Burlingame, CA), and bands were detected by the enhanced chemiluminescence detection system (ECL, Amersham). Autoradiographs were obtained by exposing nitrocellulose sheets to Kodak XAR film, and the bands were quantitated by laser densitometry.
The time course of relative cholangiocyte volume
in response to an outwardly directed NaCl gradient is shown in Fig.
1A. The osmotic gradient caused water influx
and cell swelling. The rate of the swelling response was significantly
increased by 107 M secretin treatment.
Pf values of cholangiocytes treated with several
doses of secretin are summarized in Fig. 1B. The effect of
secretin on cholangiocyte Pf was
dose-dependent, and Pf increased with
increasing concentrations of secretin up to 10
7
M (~60%); 10
6 M failed
to further stimulate Pf. Average cholangiocyte volume (in isotonic media) was not affected by any of the doses of
secretin used. As shown in Fig. 1C, the 10
7
M secretin-induced increase of cholangiocyte
Pf was inhibited by the known water channel blocker,
HgCl2, and was restored with the sulfhydryl reagent
2-mercaptoethanol (20). Similar results were seen with
10
8-10
6 M secretin (data not
shown).
Together these data suggest that secretin promotes osmotic water transport in cholangiocytes via a mechanism mediated by mercury-sensitive water channels.
Effect of Secretin on the Distribution of AQP1 in CholangiocytesTo investigate whether secretin increased
cholangiocyte Pf by inducing the translocation of
the mercury-sensitive water channel AQP1 from subcellular organelles to
cell surface, we performed quantitative immunoblotting of cholangiocyte
intracellular and plasma membranes. AQP1 protein was mostly recovered
in cholangiocyte plasma and microsomal membranes, with only negligible
amounts of AQP1 present in the remaining intracellular membrane
fraction (see "Preparation of Subcellular Membrane Fractions" under
"Materials and Methods"). Exposure of cells to secretin resulted in
an increase of AQP1 in cholangiocyte plasma membranes by (192%,
p < 0.01) and a simultaneous decrease of AQP1 in
microsomes (56%, p < 0.01) (Fig. 2).
Secretin did not alter either the yields of total membrane protein, the
specific activity of microsomal esterase, or plasma membrane alkaline
phosphatase in the cholangiocyte plasma and microsomal membrane
fractions (data not shown).
These data are consistent with a secretin-induced relocation (presumably via vesicles) of AQP1 from intracellular to plasma membranes.
Effect of Perturbations That Disrupt Vesicular TransportTo provide support for our interpretation that secretin-induced AQP1 redistribution in cholangiocytes involves a vesicular transport mechanism, we evaluated the effect of two perturbations reported by us to disturb secretin-induced exocytosis in cholangiocytes, i.e. treatment with the microtubule blocker colchicine and exposure at low temperature (10).
Pretreatment of cholangiocytes with colchicine (but not with its
inactive analog -lumicolchicine), as well as incubation at 20 and
4 °C, markedly inhibited the increase in plasma membranes and the
decrease in microsomes of AQP1 protein induced by secretin (see Fig.
3, A and B, and Fig.
4, A and B). These two
perturbations also selectively blocked the secretin-induced increase in
cholangiocyte Pf (Figs. 3C and
4C).
Together, these data suggest that secretin promotes osmotic water transport in cholangiocytes by inducing the temperature- and microtubule-dependent vesicular translocation of AQP1 from an intracellular compartment to plasma membrane.
Current concepts concerning hormonal regulation of cell membrane water permeability come primarily from studies of the kidney. In the renal collecting duct, vasopressin binds to its receptor on the basolateral membrane of tubular principal cells; the intracellular levels of cyclic AMP rise; intracellular vesicles containing AQP2 water channels fuse with the apical membrane; and water transport increases (21, 22). In contrast, the homologous water channel AQP1 is thought to be constitutively expressed in plasma membranes of renal cells (i.e. in proximal tubules and the descending limbs of Henle) and other transporting epithelia (e.g. lung, trachea, eye, pancreas, etc.) (5, 6, 12). Thus, our study in cholangiocytes provides the first evidence for hormone-regulated membrane insertion of AQP1 water channels.
Secretin is known to stimulate ductal bile secretion by binding to its
receptor on the basolateral domain of cholangiocytes (7), a
ligand-receptor interaction that also activates cyclic AMP. Cyclic AMP
then activates cystic fibrosis transmembrane regulator Cl
channels, which would operate in parallel with an apical
Cl
/HCO3
. Although the
actual solutes responsible for the osmotically driven ductal water
secretion are unknown, HCO3
as well as
Cl
are currently considered likely to be involved (1, 2). Secretin-induced bile secretion has also been shown by morphologic techniques to be associated with a decrease in cytoplasmic vesicles (8), which was interpreted as reflecting exocytic insertion into
cholangiocyte plasma membrane (10). Thus, these observations support
the occurrence of an exocytic process involved in secretin-induced ductal water secretion. In line with these observations, the results of
this study indicate that secretin enhances cholangiocyte
Pf by inducing the exocytic insertion of AQP1 into
cholangiocyte plasma membranes. Although the precise cellular
mechanisms by which secretin mediates this exocytic translocation of
AQP1 require additional study, they are likely to overlap with
processes that modulate, via a cyclic AMP cascade, the trafficking
of the vasopressin-regulated water channel AQP2 in the kidney and the
insulin-sensitive glucose transporter GLUT 4 in adipocytes and muscle
cells (11).
Our data demonstrate that secretin significantly increased cholangiocyte water permeability, an effect that was reversibly inhibited by the known water channel blocker HgCl2. These results indicate that the mercury-sensitive water channel AQP1 mediates the secretin-induced increase in cholangiocyte Pf. Although the mercury-sensitive water channel AQP2 is not expressed in cholangiocytes,2 we cannot exclude that other, as yet unidentified, mercury-sensitive water channels contribute to the secretin effect.
The dose-response relationship of the secretin-stimulated increase in
cholangiocyte Pf showed a progressive rise up to
107 M; increasing the concentration to
10
6 M failed to further increase
Pf (Fig. 1B), suggesting that
autoinhibition is activated at this concentration, a phenomenon also
reported for vasopressin-induced water permeability in the kidney
(23).
As the functional studies suggested, secretin markedly increased the amount of AQP1 in cholangiocyte plasma membranes while simultaneously decreasing the amount of AQP1 in microsomes (Fig. 2). Based on the quantitative immunoblots for AQP1 and the total membrane proteins in each cholangiocyte membrane fraction, we estimated that under basal (non-stimulated) conditions approximately 70% of the total amount of cholangiocyte AQP1 would reside in intracellular membranes, whereas the rest would be present in plasma membranes (i.e. ~30%). Interestingly, in cells in which AQP1 is constitutively expressed, most of the water channel (~95%) is associated with plasma membranes (5, 6). After secretin treatment, AQP1 became predominant in plasma membranes (i.e. about 65% of total), and this increase was proportional to the decrease of AQP1 observed in microsomes; the total amount of AQP1 in both membrane fractions was not affected by secretin. The estimated subcellular distributions of AQP1 in basal and secretin-stimulated cholangiocytes are in very good agreement with those reported for other hormone-regulated transporters, such as aquaporin 2 and GLUT 4 (24-26). It is important to mention that minor levels of cross-contamination (about 10%) between plasma and microsomal membrane fractions were observed, but this did not significantly affect the calculations. Thus, the stoichiometric nature of this relationship further supports a redistribution of preexisting AQP1 water channels from an unidentified intracellular pool (associated with microsomal membranes) to cholangiocyte plasma membrane in response to secretin.
The fact that the secretin-induced relocation of AQP1 as well as the increased cholangiocyte Pf was disturbed by two perturbations (Figs. 3 and 4) that block secretin-induced exocytosis in cholangiocytes (10) (i.e. treatment with colchicine and exposure to low temperature) is consistent with the view that a microtubule-dependent exocytic insertion of AQP1-containing vesicles mediates the secretin-induced water permeability increase in cholangiocytes. Similar observations have been described for the vasopressin-mediated increase in water permeability in the kidney, which is also dependent on the integrity of the microtubular network (27). Our results also agree with observations in renal proximal tubule cells indicating that microtubules are involved in the insertion of AQP1 into plasma membranes (28).
In conclusion, the results of this study suggest that secretin facilitates osmotic water transport in cholangiocytes by inducing the microtubule-dependent targeting of vesicles containing AQP1 water channels to the plasma membrane. We propose that this pathway provides a molecular mechanism accounting for the ability of secretin to stimulate ductal bile secretion.
We thank P. Tietz, B. Vroman, and J. Tarara for advice and assistance and D. Lubinski for secretarial help.